ScholarIQanswers from OpenAlex & ORCID
Thomas F. Gajewski
ResearcherPublications, citations & collaboration network
Thomas F. Gajewski is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas F. Gajewski have?
ScholarIQindexed works
Thomas F. Gajewski has 656 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas F. Gajewski have?
ScholarIQcitation count
Thomas F. Gajewski has 56,786 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas F. Gajewski?
ScholarIQh-index
Thomas F. Gajewski has an h-index of 95 in OpenAlex.
What is the i10-index of Thomas F. Gajewski?
ScholarIQi10-index
Thomas F. Gajewski has an i10-index of 293 in OpenAlex.
What is the ORCID of Thomas F. Gajewski?
ScholarIQorcid
The ORCID for Thomas F. Gajewski is on the source record.
What is the OpenAlex record for Thomas F. Gajewski?
ScholarIQopenalex
The OpenAlex for Thomas F. Gajewski is on the source record.
What are the most-cited papers on Thomas F. Gajewski?
ScholarIQmost cited works
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng‐Ryong Woo, Mercedes B. Fuertes, Leticia Corrales, Stefani Spranger, Michael J. Furdyna, Michael Y.K. Leung, Ryan Duggan, Ying Wang, Glen N. Barber, Katherine A. Fitzgerald, Maria-Luisa Alegre, Thomas F. Gajewski
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, Shruti Malu, Caitlin Creasy, Michael T. Tetzlaff, Chunyu Xu, Jodi A. McKenzie, Chunlei Zhang, Xiaoxuan Liang, Leila J. Williams, Wanleng Deng, Guo Chen, Rina M. Mbofung, Alexander J. Lazar, Carlos A. Torres‐Cabala, Zachary A. Cooper, Pei-Ling Chen, Trang N. Tieu, Stefani Spranger, Xiaoxing Yu, Chantale Bernatchez, Marie‐Andrée Forget, Cara Haymaker, Rodabe N. Amaria, Jennifer L. McQuade, Isabella C. Glitza, Tina Cascone, Haiyan S. Li, Lawrence N. Kwong, Timothy P. Heffernan, Jianhua Hu, Roland L. Bassett, Marcus Bosenberg, Scott E. Woodman, Willem W. Overwijk, Gregory Lizée, Jason Roszik, Thomas F. Gajewski, Jennifer A. Wargo, Jeffrey E. Gershenwald, Laszlo Radvanyi, Michael A. Davies, Patrick Hwu
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Georgina V. Long, Reinhard Dummer, Omid Hamid, Thomas F. Gajewski, Christian Caglevic, Stéphane Dalle, Ana Arance, Matteo S. Carlino, Jean‐Jacques Grob, Tae Min Kim, Lev Demidov, Caroline Robert, James Larkin, James R. Anderson, Janet Maleski, Mark M. Jones, Scott J. Diede, Tara C. Mitchell